Nanoparticle-Based Photodynamic Therapy: Current Status and Future Application to Improve Outcomes of Cancer Treatment
Authors:
- 1 January 2017
- journal article
- review article
- Published by Pharmaceutical Society of Japan
- Vol. 65 (7) , 637-641
Abstract
Photodynamic therapy (PDT) is an emerging cancer treatment that uses photosensitizers (PS), along with light to activate them, resulting in oxidation of various biological components in cancer tissues. However, since most potential PS are solubilized and given as aqueous solution, PS is non-specifically distributed in the body, leading to the induction of various side effects in normal tissues that are exposed to daylight such as skin and eyes. To overcome the problem associated with non-specific in vivo disposition of PS, various approaches have been applied to develop safer dosage forms for PS with more efficient tumor delivery and lower disposition to normal tissues. Passive drug targeting to tumors with nanoparticulate formulations has been recognized as one of the potentially useful approaches to improve the poor tissue specificity of conventional cancer chemotherapy and this approach should also be applicable for more efficient tumor delivery of PS. In this review article, several issues concerning the efficacy of PDT using nanoparticle-based formulations are discussed and our recent attempts to temporally enhance the vascular permeability within tumors with photodynamic treatment for the better therapeutic outcome of nanoparticle-based therapy are introduced.Keywords
This publication has 40 references indexed in Scilit:
- Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapyJournal of Controlled Release, 2011
- Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window‐chamber tumor modelLasers in Surgery and Medicine, 2011
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Doxorubicin-Loaded (PEG)3-PLA Nanopolymersomes: Effect of Solvents and Process Parameters on Formulation Development andIn VitroStudyMolecular Pharmaceutics, 2011
- Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membraneAngiogenesis, 2010
- Differential diagnosis of pancreatic tumors using ultrasound contrast imagingJournal of Gastroenterology, 2005
- Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of TumorsCancer Research, 2004
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acidJournal of the American Academy of Dermatology, 1993